Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Palliation
Do you constraint heterogeneity or hotspots when delivering spine SBRT for bone metastases?
Related Questions
How would you manage a patient with a high-risk asymptomatic bone metastasis with a driver mutation?
Does your choice of dose and fractionation for bone metastasis depend on the location of the metastasis in question?
Would you consider spine re-irradiation after Pluvicto?
Is there a role for radiation in palliating malignant small bowel obstruction?
Do you have a 15 fraction constraint for the LADA?
What is the optimal management of pain and loss of function due to pathologic compression fractures?
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
Do you use a comprehensive volumetric, rather than numeric, cutoff in consideration of SRS vs WBRT for brain metastases?
Would you consider palliative RT in the setting of tumor causing osteonecrosis in an elderly patient?
Would you offer 12-16 Gy in a single fraction for a symptomatic, non-vertebral bone metastasis?
